Vaccines,Hopes and Realities

Payne L.G. Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol 1980; 50: 89–100

Buller R.M.L. , Smith G.L. , Cremer K. , Notkins A.L. , and Moss B. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature 1985; 317: 813–15

Mackett M. , and Smith G.L. Vaccinia virus expression vectors. J Gen Virol 1986; 67: 2067–82

Mackett M. , Arrand Jr. , Reith R. , and Williamson J.D. Characterization of vaccinia virus recombinants expressing the Ebstein-Barr virus membrane antigen gp340. Vaccines 86, (ed. Brown F , Chanodk RM , and Lerner RA ) Cold Spring Harbour Laboratory 1986: 293–297

Robinson A. , Irons L.I. , and Ash worth L.A.E. Pertussis vaccine: present status and future prospects. Vaccine 1985; 3: 11–22

Rutter D.A. , Ashworth L.A.E. , Day A. , Funnell S. , Lovell F. , and Robinson A. Trial of a new acellular pertussis vaccine in healthy adult volunteers. Vaccine (in press)